Background: An investigation of the mechanisms underlying the production of inflammatory cytokines through the stimulation of microorganisms on gingival epithelial cells may provide insights into the pathogenesis of the initiation of periodontitis. Lipid rafts, microdomains in the cell membrane, include a large number of receptors, and are centrally involved in signal transduction. We herein examined the involvement of lipid rafts in the expression of interleukin (IL-6) and IL-8 in gingival epithelial cells stimulated by periodontal pathogens. Methods: OBA9, a human gingival cell line, was stimulated by Aggregatibacter actinomycetemcomitans or tumor necrosis factor (TNF)-α in the presence of methyl-β-cyclodextrin (MβCD). Results: A. actinomycetemcomitans or TNF-α increased IL-8 and IL-6 mRNA levels, and promoted the phosphorylation of ERK and p38 MAP kinase in OBA9. The pretreatment with MβCD abolished increases in IL-6 and IL-8 mRNA levels and the phosphorylation induced by A. actinomycetemcomitans, but did not suppress the response induced by TNF-α. The transfection of TLR4 inhibited A. actinomycetemcomitans-induced increases in IL-8 and IL-6 mRNA levels. Confocal microscopy revealed that MβCD inhibited the mobilization of TLR4 into lipid rafts. Conclusion: The mobilization of TLR4 into lipid rafts is involved in the expression of inflammatory cytokines and phosphorylation of MAP kinase in human gingival epithelial cells stimulated by A. actinomycetemcomitans.
Introduction
Periodontitis is a biofilm-associated inflammatory disease of the periodontium that is caused by a shift in the local ecology. The gingival epithelium is the first line of defense against a microbial challenge and plays a crucial role as a mechanical barrier to bacterial invasion and in innate immune responses to infectious inflammation in periodontal tissue [1, 2] . Therefore, an investigation of the interaction between the gingival epithelium and periodontopathic bacteria may provide insights into the pathogenesis of the initiation of periodontitis.
Interleukin (IL)-8 and IL-6 are well-known inflammatory cytokines and are present in diseased human periodontal tissues [3] [4] [5] [6] [7] . IL-8 levels in periodontal tissue and gingival crevicular fluid have been correlated with disease severity [8] . Furthermore, the expression of IL-8 in diseased tissue, particularly in the gingival epithelium, has been correlated with the migration of polymorphonuclear leukocytes [3, [9] [10] [11] . IL-6 is produced by several cell types, such as B and T lymphocytes, monocytes, fibroblasts, and epithelial cells, and is a major mediator of host responses to tissue injury and infection [12] . Therefore, elucidating the mechanisms underlying the production of IL-6 and IL-8 in gingival epithelial cells in the response to periodontal pathogens may contribute to a better understanding of the initiation of periodontitis. Strategies that modulate the production of IL-6 and IL-8 by gingival epithelial cells may be applicable to the treatment or prevention of periodontitis. Based on this hypothesis, we previously reported that irsogladine maleate, an anti-gastric ulcer agent, effectively prevented periodontitis by regulating the expression of IL-8 and IL-6 in gingival epithelial cells [13, 14] .
Similar to this concept, we recently demonstrated that the anti-fungal drug, amphotericin B down-regulated the Aggregatibacter actinomycetemcomitans-induced production of IL-8 and IL-6 in human gingival epithelial cells [15] . Since amphotericin B binds to cholesterol in mammalian cell membranes [16, 17] , cholesterol may be involved in the regulation of inflammatory mediators. Lipid rafts are unique biophysical entities enriched in glycosphingolipids, cholesterol, and sphingomyelin, and function as platforms in protein sorting and signal transduction [18] . Therefore, lipid rafts play roles in innate immunity on the gingival epithelium such as the activation of toll-like receptors. Previous studies showed that TLR4 is expressed in gingival epithelial cells and is involved in enhancing the expression of IL-6 and IL-8 [19] [20] [21] . Therefore, we herein investigated the roles of lipid rafts and TLR4 on the expression of IL-8 and IL-6 in gingival epithelial cells stimulated with A. actinomycetemcomitans.
Materials and Methods

Reagents and antibodies
MβCD was purchased from Sigma-Aldrich (St Louis, MO, USA). TNF-α was purchased from R&D Systems (Minneapolis, MN, USA). Porphyromonas gingivalis-LPS and Escherichia coli-LPS were purchased from InVivoGen (San Diego, CA, USA). Humedia-KB2 medium was obtained from Kurabo (Osaka, Japan). Todd-Hewitt broth was obtained from BBL R (Cockeysville, MD, USA). Yeast extract was from Difco Laboratories (Detroit, MI, USA). SB203580 and PD98059 were purchased from Calbiochem (La Jolla, CA, USA). ISOGEN was from Wako Pure Chemical Industries (Osaka, Japan). A rabbit anti-phosphorylated p38 MAP kinase antibody, rabbit anti-total p38 MAP kinase antibody, rabbit anti-phosphorylated ERK antibody, and rabbit anti-total ERK antibody were from Cell Signaling (Beverly, MA, USA). A mouse anti-human TLR4 antibody was obtained from IMGENEX (San Diego, CA, USA). Alexa Fluor488 conjugates of Cholera toxin subunit B (CT-B) were obtained from Thermo Fisher Scientific (Waltham, MA, USA). HRP-conjugated sheep anti-rabbit IgG or anti-mouse IgG and ECL Prime Western blotting detection reagents were obtained from Amersham Biosciences (Arlington Heights, IL, USA).
Culture of A. actinomycetemcomitans
A. actinomycetemcomitans Y4 (purchased from the American Type Culture Collection, Manassas, VA, USA) was grown in Todd-Hewitt broth supplemented with 1% yeast extract at 37°C for 2 days. Following their cultivation, whole cells were fixed with 1% formalin at 4°C for 12 h, harvested by centrifugation, and washed three times in PBS (pH 7.4). A portion of washed A. actinomycetemcomitans was suspended in Humedia-KB2 medium (pH 7.4) containing 10 µg/ml insulin, 5 µg/ml transferrin, 10 µM 2-mercaptoethanol, 10 µM 2-aminoethanol, and 10 nM sodium selenite. 
Cell culture
The SV40-antigen-immortalized gingival epithelial cell line, OBA9 was kindly provided by Dr. Shinya Murakami (Osaka University Graduate School of Dentistry, Osaka, Japan). OBA9 were seeded on 60-mm plastic tissue culture plates and maintained in Humedia-KB2 medium containing 10 g/ml insulin, 0.1 ng/ml hEGF, 0.67 µg/ml hydrocortisone hemisuccinate, 50 µg/ml gentamycin, 0.4% BPE, and 50 ng/ml amphotericin B (medium A) under 5% CO 2 /95% air at 37°C. When cells reached subconfluence, they were harvested and subcultured.
MTS cytotoxicity assay
The MTS assay was performed using the Cell Titer 96 R One Solution Cell Proliferation Assay kit (Promega, Madison, WI). OBA9 were seeded on 96-well microtiter plates, and maintained in 100 µl of medium A. Confluent OBA9 were treated with MβCD from 50 µM to 10 mM in Humedia-KB2 medium containing 10 µg/ml insulin, 0.1 ng/ml hEGF, 0.67 µg/ml hydrocortisone hemisuccinate, 50 µg/ml gentamycin, and 50 ng/ml amphotericin B (medium B), and were then incubated at 37°C under 5% CO 2 /95% air for 24 h. Ten microliters of Cell Titer 96 Aqueous One Solution Reagent was added to the culture at the end of the incubation period. After a 2-h incubation, absorbance was measured using a reference wavelength of 490 nm.
RNA preparation
OBA9 were seeded at a density of 2 x 10 4 cells/35-mm plastic tissue culture plate, and maintained in 2 ml of medium A. SB203580 (p38 MAP kinase inhibitor) and PD98059 (ERK inhibitor) were used to examine the involvement of p38 MAP kinase and ERK on the expressions of IL-6 and IL-8. Confluent OBA9 were pretreated with MβCD (0.1, 0.5, and 1 mM), SB203580 (10 µM), and PD98059 (10 µM) for 30 min, and then exposed to formalin-killed A. actinomycetemcomitans Y4 at 1 x 10 8 cells/ml or TNF-α (50 ng/ml) for 12 h before the end of the incubation in 2 ml of medium B. Total RNA was extracted using ISOGEN and quantified by spectrometry at 260 and 280 nm.
Measurement of IL-8 and IL-6 mRNA
First-strand cDNA synthesis was performed with 1 µg of the total RNA extract in a total volume of 10 µl (Roche, Tokyo, Japan). Real-time PCR was performed with a LightCycler system using SYBR green (Roche). The sense and anti-sense primers used were as follows: IL-8, (sense) 5'-ATG ACT TCC AAG CTG GCC GTG GCT-3 and (anti-sense) 5'-TCT CAG CCC TCT TCA AAA ACT TCT C-3'; IL-6, (sense) 5'-ATG AAC TCC TTC TCC ACA AGC GC-3' and (anti-sense) 5'-GAA GAG CCC TCA GGC TGG ACT G-3'; and GAPDH (sense) 5'-AAC GTG TCA GTG GTG GAC CTG-3' and (anti-sense) 5'-AGT GGG TGT CGC TGT TGA AGT-3'.
Immunoblotting for phosphorylated p38 MAP kinase, total p38 MAP kinase, phosphorylated ERK, and total ERK
In order to detect phosphorylated p38 MAP kinase, total p38 MAP kinase, phosphorylated ERK, and total ERK, confluent OBA9 were exposed to A. actinomycetemcomitans Y4 or TNF-α in the presence or absence of MβCD at 50 µM for 30 min. Cells were lysed in 200 µl of SDS sample buffer (62.5 mM Tris-HCl, 2% SDS, 10% glycerol, 50 mM dithiothreitol, and 0.01% bromophenol blue). Samples were resolved on a 10% SDS-polyacrylamide gel by electrophoresis under non-reducing conditions and electrophoretically transferred onto membranes (Bio-Rad Laboratories, Hercules, CA). The membranes were blocked with 5% non-fat dried milk for 1 h and then reacted with the rabbit anti-phosphorylated-p38 MAP kinase antibody, rabbit anti-total p38 MAP kinase antibody, rabbit anti-phosphorylated ERK antibody, or rabbit anti-total ERK antibody overnight. The membrane was incubated with HRP-conjugated sheep anti-rabbit IgG in TBS at room temperature for 1 h. Immunodetection was performed according to the manual supplied with the ECL Prime Western blotting detection reagents.
Small interfering RNA (siRNA) knockdown of TLR4
Validated TLR4 siRNA and negative-control siRNA were obtained from Invitrogen (Van Allen Way Carlsbad, CA). OBA9 were seeded at a density of 2.0 × 10 4 cells/6-well plastic culture plates and cultured in medium A at 37°C for 24 h. Thirty nanomoles of TLR4 siRNA and negative control siRNA were transfected into cells using Lipofectamine RNAiMAX reagent (Invitrogen), according to the manufacturer's instructions. Cells treated with or without stimulants were collected after a 48-h incubation.
Results
Effects of MβCD on IL-6 and IL-8 mRNA levels in OBA9 stimulated with A. actinomycetemcomitans or TNF-α
The MTS assay was performed to determine the toxicity of MβCD. OBA9 were incubated with various concentrations of MβCD for 24 h. The MTS assay revealed that MβCD at less than 2.5 mM had a negligible effect on OBA9 viability. However, MβCD at 5 mM significantly decreased in viability (data not shown). MβCD at 5 mM markedly affected cell morphology, whereas concentrations less than 2.5 mM did not (data not shown).
Real-time PCR was used to investigate the effects of MβCD on A. actinomycetemcomitans-induced inflammatory mediators. MβCD was added to the cell culture 30 min before the stimulation with A. actinomycetemcomitans. The exposure of OBA9 to Cell A. actinomycetemcomitans increased IL-6 and IL-8 mRNA levels. However, the addition of MβCD to the culture significantly abolished A. actinomycetemcomitans-induced increases in these levels (Fig. 1) . On the other hand, although TNF-α also increased the mRNA levels of IL-6 and IL-8 in OBA9, MβCD had a negligible effect on TNF-α-induced increases in IL-6 and IL-8 ( Fig. 1) .
Since the phosphorylation of ERK and p38 MAP kinase is involved in the enhancement of IL-6 and IL-8 levels in gingival epithelial cells, the effects of MβCD on the A. actinomycetemcomitans-or TNF-α-induced phosphorylation of ERK and p38 MAP kinase were examined. MβCD attenuated the A. actinomycetemcomitans-induced phosphorylation of ERK and p38 MAP kinase in OBA9, but did not affect TNF-α-induced phosphorylation. Furthermore, the pretreatment with SB203580 at 10 µM for 30 min inhibited A. actinomycetemcomitans-induced increases in IL-8 and IL-6 mRNA levels in OBA9. PD98059 also attenuated the A. actinomycetemcomitans-induced increase in IL-8, but not in IL-6 levels in OBA9 (Fig. 2) .
Involvement of TLR4 in the enhancement of IL-6 and IL-8 mRNA levels in OBA-9
In order to determine the involvement of TLR2 or TLR4 on A. actinomycetemcomitansinduced increases in IL-6 and IL-8 levels, P. gingivalis-LPS (TLR2 ligand) or E. coli-LPS (TLR4 ligand) was added to the culture in the presence or absence of MβCD. MβCD did not influence the increases induced in IL-8 and IL-6 mRNA levels by P. gingivalis-LPS, whereas it suppressed those induced by E. coli-LPS. In addition, the transfection of TLR4 inhibited A. actinomycetemcomitans-induced increases in IL-8 and IL-6 mRNA levels (Fig. 3) . 
Involvement of TLR4 in A. actinomycetemcomitans-induced lipid rafts
Since the results of the present study suggest that reductions in IL-6 and IL-8 mRNA levels are medicated through TLR4, we investigated the involvement of TLR4 in A. actinomycetemcomitans-induced lipid rafts in OBA9 in more detail. Confocal microscopy showed that TLR was expressed apart from CT-B in non-stimulated cells. However, the co-localization of TLR4 and CT-B (pointed by arrows) was observed after a 5-or 15-min stimulation with A. actinomycetemcomitans (Fig. 4) . Furthermore, MβCD inhibited the colocalization of TLR4 and CT-B in OBA9 (Fig. 5A) . In order to validate the co-localization procedure of TLR4 and CT-B on images of cells, Manders coefficient was calculated by an intensity correlation analysis of Alexa Fluor 594 and Alexa Fluor 488. The average of Manders coefficient for TLR4 and CT-B is shown in Fig. 5B . The addition of MβCD inhibited A. actinomycetemcomitans-induced increases in the co-localization of TLR4 and CT-B in OBA9.
Discussion
In the present study, we demonstrated that lipid rafts are involved in A. actinomycetemcomitans-induced increases in IL-6 and IL-8 levels in cultures of human gingival epithelial cells. Furthermore, the mobilization of TLR4 into lipid rafts by A. actinomycetemcomitans was involved in the increases observed in IL-6 and IL-8 levels in human gingival epithelial cells. These results suggest that lipid rafts play a role in A. actinomycetemcomitans-induced increases in IL-6 and IL-8 levels in gingival epithelial cells through TLR4.
MβCD treatments have previously been described as a rapid and efficient method for selectively removing cholesterol from the plasma membranes of cultured cells [22, 23] , and MβCD has been extensively used as a cholesterol-depleting reagent. Therefore, we utilized MβCD in order to investigate whether the phosphorylation of MAP kinase and cytokine secretion induced by A. actinomycetemcomitans or TNF-α depends on plasma membrane cholesterol. Our results indicated that MβCD inhibited the increases in the production of IL-8 and into rafts. These results suggest that the translocation of TLR4 by A. actinomycetemcomitans is followed by the phosphorylation of p38 MAP kinase and ERK, and the translocation of the receptor into lipid rafts is a specific event for TLR4, but not for TNF-α receptors or TLR2 in human gingival epithelial cells.
The relationship between lipid rafts and TLR4 in inflammatory responses has been reported previously in several cell types. The depletion of cholesterol or disruption of lipid rafts by MβCD has been shown to down-regulate the TLR4-mediated inflammatory responses induced by E. coli-LPS [24] [25] [26] . In addition, MβCD inhibited Helicobacter pylori-induced increases in the production of IL-8 by regulating the mobilization of TLR4 into lipid rafts in gastric epithelial cells [27] . Furthermore, the suppression of TLR4 recruitment into lipid rafts by surfactant lipid or ethanol caused a reduction in the LPS-induced cellular activation of macrophage-like cells and lung epithelial cells [26, 28] . Thus, the molecules inhibiting the translocation of TLR4 may also result in the suppression of inflammatory responses in gingival epithelial cells. For example, glycyrrhizin has been shown to inhibit the LPS-induced translocation of TLR4 to lipid rafts, thereby attenuating LPS-mediated inflammatory responses [29] . Previous studies have shown that the accumulation of cholesterol in membranes is followed by the activation of downstream signaling events, such as MAP kinase and PI3 kinase. A treatment with MβCD led to the selective attenuation of MAP kinase activation through ERK1/2 without affecting the translocation of TLR4 in macrophages [25] . On the other hand, the accumulation of free cholesterol in membranes activates TLR3 and TLR4 in addition to the sustained phosphorylation of p38 MAP kinase in macrophages [30] . This is consistent with the present results showing that MβCD inhibited the phosphorylation of p38 MAP kinase and ERK in gingival epithelial cells. We previously reported that amphotericin, a cholesterol-binding agent, down-regulated A. actinomycetemcomitansinduced inflammatory responses by regulating MAP kinase signaling in gingival epithelial cells [15] . Therefore, amphotericin may also regulate TLR4-mediated MAP kinase signaling and inflammatory responses in gingival epithelial cells.
A recent study has indicated that CT-B binds to ganglioside GM1 and the removal of cholesterol does not influence binding to GM1 in Hela cells [31] . Therefore, changes in raft labeling after cholesterol extraction needed to be examined using other raft markers such as ostreolysin, which binds to membranes rich in cholesterol and sphingomyelin. Flotillin-1 and caveolin-1 are raft-associated transmembrane proteins that attach to two raft components and are co-distributed with ostreolysin [32] . Therefore, we performed double immunostaining of TLR4 and flotillin-1 or caveolin-1 in OBA9. The single staining of flotillin-1 or caveolin-1 was obtained, similar to CT-B in OBA9, but it was not possible to obtain merged images (unpublished data).
In the present study, we indicated that lipid rafts are involved in inflammatory responses in gingival epithelial cells stimulated by A. actinomycetemcomitans. Previous studies demonstrated that lipid rafts play a role in the regulation of cellular function in epithelial cells, such as the epithelial barrier or bacterial invasion [33] [34] [35] . Collectively, previous findings and the results of the present study indicate that A. actinomycetemcomitans-induced alternations in lipid rafts are involved in the weakening of the gingival epithelial barrier or bacterial invasion. Further studies on the mechanisms underlying innate cellular responses against periodontopathic bacteria may lead to treatments for or the prevention of periodontal disease. The results of the present study suggest that the regulation of cholesterol represents a novel method for suppressing inflammatory cytokines. 
